Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Nashville, TN.
Vanderbilt University School of Medicine, Nashville, TN.
Ann Surg. 2022 Aug 1;276(2):e114-e119. doi: 10.1097/SLA.0000000000004484. Epub 2020 Nov 17.
In a multicenter, international cohort, we aimed to validate a modified Sequential Organ Failure Assessment (mSOFA) using the Richmond Agitation-Sedation Scale, hypothesized as comparable to the Glasgow Coma Scale (GCS)-based Sequential Organ Failure Assessment (SOFA).
The SOFA score, whose neurologic component is based on the GCS, can predict intensive care unit (ICU) mortality. But, GCS is often missing in lieu of other assessments, such as the also reliable and validated Richmond Agitation Sedation Scale (RASS). Single-center data suggested an RASS-based SOFA (mSOFA) predicted ICU mortality.
Our nested cohort within the prospective 2016 Fourth International Study of Mechanical Ventilation contains 4120 ventilated patients with daily RASS and GCS assessments (20,023 patient-days, 32 countries). We estimated GCS from RASS via a proportional odds model without adjustment. ICU mortality logistic regression models and c-statistics were constructed using SOFA (measured GCS) and mSOFA (measured RASS-estimated GCS), adjusted for age, sex, body-mass index, region (Europe, USA-Canada, Latin America, Africa, Asia, Australia-New Zealand), and postoperative status (medical/surgical).
Cohort-wide, the mean SOFA=9.4+/-2.8 and mean mSOFA = 10.0+/-2.3, with ICU mortality = 31%. Mean SOFA and mSOFA similarly predicted ICU mortality (SOFA: AUC = 0.784, 95% CI = 0.769-0.799; mSOFA: AUC = 0.778, 95% CI = 0.763-0.793, P = 0.139). Across models, other predictors of mortality included higher age, female sex, medical patient, and African region (all P < 0.001).
We present the first SOFA modification with RASS in a "real-world" international cohort. Estimating GCS from RASS preserves predictive validity of SOFA to predict ICU mortality. Alternative neurologic measurements like RASS can be viably integrated into severity of illness scoring systems like SOFA.
在一项多中心、国际化的队列研究中,我们旨在验证改良序贯器官衰竭评估(mSOFA),该方法使用了 Richmond 镇静-躁动评分,假设其与基于格拉斯哥昏迷评分(GCS)的序贯器官衰竭评估(SOFA)相当。
SOFA 评分的神经学部分基于 GCS,可预测重症监护病房(ICU)的死亡率。但是,由于其他评估方法(如同样可靠和有效的 Richmond 镇静-躁动评分(RASS))的使用,GCS 经常缺失。单中心数据表明,基于 RASS 的 SOFA(mSOFA)可预测 ICU 死亡率。
我们的研究嵌套于前瞻性 2016 年第四次机械通气国际研究中,包含 4120 例接受每日 RASS 和 GCS 评估的机械通气患者(20023 患者天,32 个国家)。我们通过无调整的比例优势模型从 RASS 估计 GCS。使用 ICU 死亡率的 logistic 回归模型和 C 统计量,构建了 SOFA(测量的 GCS)和 mSOFA(测量的 RASS 估计的 GCS)的模型,这些模型调整了年龄、性别、体重指数、地区(欧洲、美国-加拿大、拉丁美洲、非洲、亚洲、澳大利亚-新西兰)和术后状态(内科/外科)。
整个队列中,SOFA 的平均值为 9.4±2.8,mSOFA 的平均值为 10.0±2.3,ICU 死亡率为 31%。SOFA 和 mSOFA 均能很好地预测 ICU 死亡率(SOFA:AUC=0.784,95%CI=0.769-0.799;mSOFA:AUC=0.778,95%CI=0.763-0.793,P=0.139)。在各模型中,死亡率的其他预测因素包括年龄较高、女性、内科患者和非洲地区(均 P<0.001)。
我们首次在一个“真实世界”的国际化队列中提出了使用 RASS 改良的 SOFA。从 RASS 估计 GCS 保留了 SOFA 预测 ICU 死亡率的预测有效性。像 RASS 这样的替代神经学测量方法可以有效地整合到 SOFA 等疾病严重程度评分系统中。